JP2014532754A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532754A5
JP2014532754A5 JP2014540612A JP2014540612A JP2014532754A5 JP 2014532754 A5 JP2014532754 A5 JP 2014532754A5 JP 2014540612 A JP2014540612 A JP 2014540612A JP 2014540612 A JP2014540612 A JP 2014540612A JP 2014532754 A5 JP2014532754 A5 JP 2014532754A5
Authority
JP
Japan
Prior art keywords
oxo
dihydro
compound
ylmethyl
oxazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014540612A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532754A (ja
JP6030146B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/056236 external-priority patent/WO2013068948A1/en
Publication of JP2014532754A publication Critical patent/JP2014532754A/ja
Publication of JP2014532754A5 publication Critical patent/JP2014532754A5/ja
Application granted granted Critical
Publication of JP6030146B2 publication Critical patent/JP6030146B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014540612A 2011-11-08 2012-11-07 2−オキソ−オキサゾリジン−3,5−ジイル抗生物質誘導体 Expired - Fee Related JP6030146B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IBPCT/IB2011/054968 2011-11-08
IB2011054968 2011-11-08
PCT/IB2012/056236 WO2013068948A1 (en) 2011-11-08 2012-11-07 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Publications (3)

Publication Number Publication Date
JP2014532754A JP2014532754A (ja) 2014-12-08
JP2014532754A5 true JP2014532754A5 (enExample) 2015-12-03
JP6030146B2 JP6030146B2 (ja) 2016-11-24

Family

ID=47258051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014540612A Expired - Fee Related JP6030146B2 (ja) 2011-11-08 2012-11-07 2−オキソ−オキサゾリジン−3,5−ジイル抗生物質誘導体

Country Status (21)

Country Link
US (1) US9079922B2 (enExample)
EP (1) EP2776431B1 (enExample)
JP (1) JP6030146B2 (enExample)
KR (1) KR20140096337A (enExample)
AR (1) AR088691A1 (enExample)
AU (1) AU2012335207B2 (enExample)
BR (1) BR112014011064A8 (enExample)
CA (1) CA2854264A1 (enExample)
CL (1) CL2014001154A1 (enExample)
ES (1) ES2581056T3 (enExample)
HK (1) HK1202288A1 (enExample)
IL (1) IL232463A0 (enExample)
IN (1) IN2014CN04126A (enExample)
MX (1) MX344529B (enExample)
PH (1) PH12014500831A1 (enExample)
PL (1) PL2776431T3 (enExample)
RU (1) RU2616609C2 (enExample)
SG (1) SG11201401710PA (enExample)
TW (1) TWI594996B (enExample)
WO (1) WO2013068948A1 (enExample)
ZA (1) ZA201404176B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4833385B1 (ja) 2008-10-07 2011-12-07 アクテリオン ファーマシューティカルズ リミテッド 三環式オキサゾリジノン抗生物質化合物
MA38588B1 (fr) 2013-04-16 2018-04-30 Idorsia Pharmaceuticals Ltd Dérivés bi-aromatiques antibactériens
AR096135A1 (es) 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
MA41169A (fr) 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
MA41168A (fr) 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
CA3012569A1 (en) * 2016-02-08 2017-08-17 Redx Pharma Plc Antibacterial compounds
GB201602235D0 (en) * 2016-02-08 2016-03-23 Redx Pharma Plc Antibacterial compounds
EP3413976A1 (en) * 2016-02-08 2018-12-19 Redx Pharma PLC Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
EP3468975B1 (en) 2016-06-08 2020-04-01 Aziende Chimiche Riunite Angelini Francesco A.C.R. New antibacterial compounds
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
US10912780B2 (en) 2017-06-08 2021-02-09 Bugworks Research, Inc. Heterocyclic compounds useful as anti-bacterial agents and method for production thereof
CN111527093B (zh) * 2017-11-29 2023-06-09 巴格沃克斯研究有限公司 抗菌杂环化合物及其合成
JP2024529132A (ja) * 2021-08-13 2024-08-01 バグワークス・リサーチ・インディア・ピーヴィーティー・リミテッド 抗生物質ピラジノチアジン誘導体及びその調製方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
DE2362553A1 (de) 1972-12-18 1974-06-20 Dainippon Pharmaceutical Co Neue piperazinderivate
SE444566B (sv) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
GB1598915A (en) 1977-09-20 1981-09-23 Bellon Labor Sa Roger 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
CS274601B2 (en) 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS62205060A (ja) 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd 8位置換キノロンカルボン酸誘導体
DK164287A (da) 1986-03-31 1987-10-01 Sankyo Co Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse
JP2631854B2 (ja) 1987-12-23 1997-07-16 藤本製薬株式会社 新規な1,8−ナフチリジン誘導体
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
AU2003244235A1 (en) 2002-06-28 2004-01-19 Kaneka Corporation Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates
MXPA05011654A (es) * 2003-04-30 2005-12-15 Morphochem Ag Komb Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
ES2310299T5 (es) * 2003-12-18 2014-02-10 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibióticos híbridos a base de oxazolidinona-quinolona
BRPI0514381A (pt) 2004-07-30 2008-06-10 Palumed Sa compostos hìbridos de aminoquinolina-antibiótico, composições farmacêuticas, método de preparação e uso destes
DE602005015341D1 (de) 2004-09-01 2009-08-20 Ubitrak Inc System zum identifizieren und zählen von spieljetons
US20090156577A1 (en) 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
US7709496B2 (en) 2006-04-06 2010-05-04 Glaxo Group Limited Antibacterial agents
CL2007003232A1 (es) * 2006-11-10 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de 5-hidroximetil oxazolidin-2-ona; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar y prevenir infecciones bacterianas.
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
JP5323088B2 (ja) * 2007-12-18 2013-10-23 アクテリオン ファーマシューティカルズ リミテッド 5−アミノシクリルメチル−オキサゾリジン−2−オン誘導体
CA2713187C (en) * 2008-02-22 2016-06-07 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives
JP4833385B1 (ja) 2008-10-07 2011-12-07 アクテリオン ファーマシューティカルズ リミテッド 三環式オキサゾリジノン抗生物質化合物
ES2395491T3 (es) * 2008-10-10 2013-02-13 Actelion Pharmaceuticals Ltd. 2-Benzotiofenil y 2-naftil-oxazolidinonas y sus análogos azaisósteros como agentes antibacterianos
JP5490809B2 (ja) * 2008-10-10 2014-05-14 アクテリオン ファーマシューティカルズ リミテッド オキサゾリジニル抗生物質
TW201121965A (en) 2009-09-28 2011-07-01 Lg Life Sciences Ltd Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis
CN101792443A (zh) 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途

Similar Documents

Publication Publication Date Title
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
RU2501799C2 (ru) Поизводные оксазолидинона
TWI248932B (en) Respiratory syncytial virus replication inhibitors
JP2005525324A5 (enExample)
JP2013539777A5 (enExample)
JP2014513110A5 (enExample)
JP2009534386A5 (enExample)
JP2017515844A5 (enExample)
JP2016512511A5 (enExample)
JP2013545798A5 (enExample)
JP2014525432A5 (enExample)
IL187690A (en) Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer
JP2017504611A5 (enExample)
JP2015514808A5 (enExample)
JP2010265321A5 (enExample)
JP2010132677A5 (enExample)
JP2010510999A5 (enExample)
JP2012515787A5 (enExample)
JP2016511262A5 (enExample)
JP2020529998A5 (enExample)
JP2020512337A5 (enExample)
JP2012515788A5 (enExample)
JP2016539157A5 (enExample)
RU2009121812A (ru) Производные 5-гидроксиметилоксазолидин-2-она
JP2016512507A5 (enExample)